Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

ClinicalTrials.gov ID: NCT02512588

Public ClinicalTrials.gov record NCT02512588. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, placebo-controlled, double-blind, multiple cohort, fixed-dose multiple crossover, dose-finding study of oral BTD-001 in adult patients with IH or Narcolepsy without cataplexy (Type 2).

Study identification

NCT ID
NCT02512588
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Balance Therapeutics
Industry
Enrollment
120 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2015 (Actual)
Primary completion
Feb 2018 (Actual)
Completion
Feb 2018 (Actual)
Last update posted
Jan 16, 2019

2015 – 2018

United States locations

U.S. sites
23
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Sleep Disorders Center of Alabama Birmingham Alabama 35213 —
Stanford Medicine Sleep Center Palo Alto California 94304 —
Pacific Research Network San Diego California 92103 —
Empire Clinical Research Upland California 91786 —
REM Sleep Medicine, Colorado Sleep Institute Boulder Colorado 80301 —
PAB Clinical Research Brandon Florida 33511 —
Clinical Research Group of St. Petersburg St. Petersburg Florida 33707 —
Emory University School of Medicine Emory Sleep Center Atlanta Georgia 30329 —
NeuroTrials Research Inc Atlanta Georgia 30342 —
SleepMed of Central Macon Georgia 31201 —
Kentucky Research Group, Louisville Kentucky 40218 —
The Center for Sleep and Wake Disorders Chevy Chase Maryland 20815 —
NeuroCare Center for Sleep Newton Massachusetts 02459 —
Neurological Associate Maplewood Minnesota 55109 —
Clayton Sleep Institute St Louis Missouri 63143 —
Columbia University Medical Center New York New York 10032 —
Wake Research Associates Raleigh North Carolina 27612 —
Community Research Management Assoc. Cincinnati Ohio 45255 —
Lynn Institute Oklahoma City Oklahoma 73112 —
SleepMed of South Carolina Columbia South Carolina 29201 —
Future Search Trials of Neurology Austin Texas 78731 —
Houston Sleep Center Houston Texas 77063 —
Swedish Medical Center Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02512588, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 16, 2019 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02512588 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →